Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats
Oxidative Medicine and Cellular Longevity · 2025
DOI: 10.1155/omcl/7684652 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oxidative Medicine and Cellular Longevity, 2025. Verfasst von Hossein M Elbadawy und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, 42353, Medina, Saudi Arabia, taibahu.edu.sa. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Sirtuin 1, Proto-Oncogene Proteins c-akt, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taibah University.
Abstract (Originalsprache)
Background and Purpose Liver fibrosis poses a major global health burden, contributing substantially to morbidity and mortality worldwide. This study aims to assess the potential novel mechanisms behind the anti‐fibrotic effects of sotagliflozin (Sota) in thioacetamide (TAA)‐induced liver fibrosis in rats. Experimental Approach To induce liver fibrosis in rats, 100 mg/kg of TAA was injected intraperitoneally triweekly for 6 weeks. Treated groups were orally administered sotagliflozin (10 and 20 mg/kg) for 4 weeks, concurrent with TAA injections. Key Results Alongside the histological alterations, the elevation of liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST), lipid profiles total cholesterol (TC) and triglycerides (TAG), cytokines tumor necrosis factor‐alpha (TNF‐α) and interleukin‐6 (IL‐6), apoptotic markers (caspase‐3 and Bcl2 associated X protein [Bax] BAX), phosphatidylinositol 3‐kinase (PI3K), phosphorylated protein kinase B (p‐AKT), and the lipid peroxidation marker malondialdehyde (MDA) indicated liver dysfunction induced by TAA. Furthermore, indicators of liver fibrosis encompassed reduced levels of albumin, antioxidants; glutathione (GSH), superoxide dismutase (SOD), heme oxygenase‐1 (HO‐1), and nuclear factor erythroid 2‐related factor 2 (Nrf2), antiapoptotic protein B‐cell lymphoma‐2 (BCL2), sirtuin‐1 (SIRT1) expression, and histopathological alterations. Conclusion and Implications This study demonstrated that daily oral treatment with sotagliflozin markedly upregulated antioxidant markers such as SIRT1 and Nrf2, attenuated TNF‐α, and reduced apoptotic and fibrogenic markers, thereby protecting against TAA‐induced liver fibrosis. This may have occurred through the augmentation of SIRT1/Nrf2 expression, the inhibition of PI3K/AKT, resulting in the suppression of apoptosis and inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, 42353, Medina, Saudi Arabia, taibahu.edu.sa.
- Health and Life Research Center, Taibah University, 42353, Madinah, Saudi Arabia, taibahu.edu.sa.
- Department of Pharmacology, Faculty of Veterinary Medicine, Cairo University, Giza, 12211, Egypt, cu.edu.eg.
- Department of Pharmacology, National Research Centre, Medical Research and Clinical Studies Institute, 33 El-Bohouth Street, Dokki, Giza, 12622, Egypt, nrc.sci.eg.
- Department for Life Quality Studies, Rimini Campus, University of Bologna, Corso d'Augusto 237, Rimini, 47921, Italy, unibo.it.
- Department of Molecular Food Chemistry and Food Development, Institute of Food and One Health, Gottfried Wilhelm Leibniz University Hannover, Am Kleinen Felde 30, 30167, Hannover, Germany, uni-hannover.de.
ORCID-Profile: Hany M Fayed, Tuba Esatbeyoglu, Marawan A Elbaset
Förderung
- Taibah University
Zitieren
APA
Elbadawy, H. M., Almikhlafi, M. A., Alsubhi, M. H., Shokry, A. A., Fayed, H. M., Mohamed, B. M. S. A., Afifi, S. M., Esatbeyoglu, T., Korany, R. M. S., & Elbaset, M. A. (2025). Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/omcl/7684652
Vancouver
Elbadawy HM, Almikhlafi MA, Alsubhi MH, Shokry AA, Fayed HM, Mohamed BMSA, et al. Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats. Oxidative Medicine and Cellular Longevity. 2025. doi:10.1155/omcl/7684652
BibTeX
@article{Elbadawy2025,
author = {Elbadawy, Hossein M and Almikhlafi, Mohannad A and Alsubhi, Mohammed H and Shokry, Aya A and Fayed, Hany M and Mohamed, Bassim M S A and Afifi, Sherif M and Esatbeyoglu, Tuba and Korany, Reda M S and Elbaset, Marawan A},
title = {Sotagliflozin Modulation of SIRT1/Nrf2 and PI3K/AKT Signaling Pathway Ameliorates Experimental Liver Fibrosis in Rats},
journal = {Oxidative Medicine and Cellular Longevity},
year = {2025},
doi = {10.1155/omcl/7684652}
}
EUVIMED